Concord Acquisition II Corp (CNDA)

Concord Acquisition II Corp is a common stock listing on OTC Markets tied to a company that has not reported significant operating activities. Its business focus is on completing a merger, share exchange, asset acquisition, stock purchase, reorganization, or another similar business combination with one or more operating businesses. The company was incorporated in 2021 and is based in New York, New York. As a special-purpose acquisition company structure, its activities are centered on identifying and executing a transaction rather than running a traditional operating business.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-CNDA
$11.23
-10.2% Downside
Fair
Not available
Not available
Great
0.0%
November 6, 2026
75.9x
87.637 M
87.514 M
0.0%
0.1%
-56.3
-17.1%
Valuation • Fair Value

Concord Acquisition II Corp (OTC-CNDA) Fair Value by Valuation Model

Review the available estimates for Concord Acquisition II Corp (OTC-CNDA), including Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$11.23

Estimated downside of 10.2% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

Ben Graham Formula Value

$1.83

Classic Ben Graham valuation formula reference.

Comps Fair Value

$11.23

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Concord Acquisition II Corp (OTC-CNDA) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Concord Acquisition II Corp (OTC-CNDA)

Review the profitability and growth indicators currently supported by the latest data.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Concord Acquisition II Corp (OTC-CNDA) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Concord Acquisition II Corp (OTC-CNDA)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Altman Z-Score

-56.3

Lower score that deserves closer risk review.

FCF / Net Income

-17.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Concord Acquisition II Corp (OTC-CNDA). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Concord Acquisition II Corp (OTC-CNDA)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 6, 2026

Days to Earnings

49

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Concord Acquisition II Corp (OTC-CNDA), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Concord Acquisition II Corp (OTC-CNDA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Concord Acquisition II Corp (OTC-CNDA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Concord Acquisition II Corp (OTC-CNDA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Concord Acquisition II Corp (OTC-CNDA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Concord Acquisition II Corp (OTC-CNDA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Concord Acquisition II Corp (OTC-CNDA) Stock FAQ

Data-supported answers about Concord Acquisition II Corp (OTC-CNDA), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$11.23
Estimated downside 10.2%
Valuation Rating
Overvalued
Estimated downside of 10.2%
Financial Health
Great
Current financial-health read

The current fair value estimate for Concord Acquisition II Corp (OTC-CNDA) is $11.23. This implies an estimated downside of 10.2% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 10.2% versus the current market price.

The current financial health read for Concord Acquisition II Corp (OTC-CNDA) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Concord Acquisition II Corp (OTC-CNDA) is November 6, 2026.

The latest available data indicates no current dividend yield for Concord Acquisition II Corp (OTC-CNDA).

The current P/E ratio listed for Concord Acquisition II Corp (OTC-CNDA) is 75.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Concord Acquisition II Corp is 87.637 M.

The current enterprise value listed for Concord Acquisition II Corp is 87.514 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Concord Acquisition II Corp is OTC-CNDA, and the stock is listed on OTC Markets.

Concord Acquisition II Corp (OTC-CNDA) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Concord Acquisition II Corp is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Concord Acquisition II Corp is 0.1%. Free float helps investors understand how much of the share base is available for public trading.